You can receive insights into any symbol that we track. You'll see relevant statistics, signals, pricing data, etc.
Business Units or Product Lines |
Glenmark Pharmaceuticals Ltd. operates through various business units such as Specialty Pharmaceuticals, Active Pharmaceutical Ingredients (API), and Generic Drugs. They also focus on innovative therapeutic segments including Dermatology, Oncology, and Respiratory products. |
Business Models for Each Product Line |
Glenmark generates revenue primarily through the development, manufacturing, and marketing of generic pharmaceuticals and active pharmaceutical ingredients. Specialty pharmaceuticals focus on branded formulations, where innovation and patents provide a competitive edge. Major expenses include R&D costs, manufacturing and production expenses, and sales and marketing costs. |
Future Opportunities for Growth |
Glenmark sees growth opportunities in expanding its specialty and innovative products, particularly in the novel biological targets and biosimilars. Emerging markets present an additional area for expansion. The company's focus on developing drugs in oncology and respiratory segments using its proprietary technology platforms is also seen as a potential growth driver. |
Potential Major Risks |
The company faces risks such as patent litigation, regulatory compliance issues, and drug pricing pressures. Currency fluctuations and geopolitical instability in key markets could also impact financial performance. Additionally, high R&D expenditure with uncertain outcomes poses a significant risk to its business strategy. |
Learn More about Glenmark Pharmaceuticals Ltd:
Company Insights by Algobear (ChatGPT);
Tell me more about Glenmark Pharmaceuticals Ltd's latest earnings (GLENMARK:Nse)
Who are some of Glenmark Pharmaceuticals Ltd's competitors? (GLENMARK:Nse)
Are analysts bullish on Glenmark Pharmaceuticals Ltd? Please show it in a table format. (GLENMARK:Nse)
Also read:
https://finance.yahoo.com/GLENMARK.NS/profile
| Market Cap-Display | Market Cap-Actual | Market Cap | Enterprise Value-Display | Enterprise Value-Actual | Enterprise Value | Trailing P/E | Forward P/E | Price/Sales | Price/Book | Enterprise Value/Revenue | Enterprise Value/EBITDA | Profit Margin | Operating Margin | Return on Assets | Return on Equity | Revenue-Display | Revenue-Actual | Revenue | Quarterly Revenue Growth | EBITDA-Display | EBITDA-Actual | EBITDA | Diluted EPS | Total Cash-Display | Total Cash-Actual | Total Cash | Total Debt-Display | Total Debt-Actual | Total Debt | Total Debt/Equity | Current Ratio | Operating Cash Flow-Display | Operating Cash Flow-Actual | Operating Cash Flow | Levered Free Cash Flow-Display | Levered Free Cash Flow-Actual | Levered Free Cash Flow | % Held by Insiders | % Held by Institutions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 45129.58 Cr | 451295805440.0 | 45129.58 | 46982.26 Cr | 469822570496.0 | 46982.26 | 43.16 | 37.65 | 3.36 | 5.25 | 3.5 | 19.06 | 7.79% | 13.69% | 8.14% | 12.54% | 13435.46 Cr | 134354616320.0 | 13435.46 | -16.1% | 2465.1 Cr | 24651030528.0 | 2465.1 | 37.05 | 1705.23 Cr | 17052279808.0 | 1705.23 | 2472.67 Cr | 24726669312.0 | 2472.67 | 0.27940000000000004 | 1.56 | -82760.0 lakh | -8275950080.0 | -827.6 | -153750.0 lakh | -15374954496.0 | -1537.5 | 49.62% | 29.22% |
source:https://finance.yahoo.com/GLENMARK.NS/key-statistics
source:https://www.google.com/finance/quote/GLENMARK:NSE
| Key | Weighted | 5D | 1M | 3M | 6M | 1Y | 3Y | 10Y |
|---|---|---|---|---|---|---|---|---|
| Upside % (high) | -0.29% | -1.08% (1610.9) | -1.08% (1610.9) | -1.08% (1610.9) | 1.81% (1658) | 12.43% (1830.95) | 12.43% (1830.95) | 12.43% (1830.95) |
| Downside % (low) | 18.2% | 9.53% (1473.3) | 16.77% (1355.4) | 21.68% (1275.5) | 21.68% (1275.5) | 36.31% (1037.15) | 78.6% (348.5) | 90.07% (161.65) |
| Spread % | -18.49% | -10.61% | -17.85% | -22.76% | -19.86% | -23.88% | -66.17% | -77.64% |
GLENMARK's price used for computing the stats is 1628.5 as on date
| Key | Today | 5D | 2W | 1M | 3M | 6M | 1Y | 3Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|
| Last Price-Trend PrevClose | 1.83% | 8.75% | 17.15% | 14.77% | 24.0% | 7.04% | 38.45% | 302.94% | 107.15% |
| Last Price | 1628.5 | 1628.5 | 1628.5 | 1628.5 | 1628.5 | 1628.5 | 1628.5 | 1628.5 | 1628.5 |
| Trend-Previous Close | 1599.2 | 1497.5 | 1390.1 | 1418.9 | 1313.35 | 1521.45 | 1176.2 | 404.15 | 786.15 |
GLENMARK's symbol cumulative return percent is computed basis data from date
| 5D | 2W | 1M | 3M | 6M | 1Y | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5D window |
5D Opportunity:
returns:
8.75%
(12.68%),
p.close: 1497.5
entry:
1687.4,
exit:
1687.11,
min.ret:
0.02%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
8.75%
(12.88%),
p.close: 1497.5
entry:
1690.31,
exit:
1707.07,
min.ret:
-0.99%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-APPROACHING
returns:
8.75%
(9.48%),
p.close: 1497.5
entry:
1639.53,
exit:
1643.41,
min.ret:
-0.24%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-ACTIVE
returns:
8.75%
(7.7%),
p.close: 1497.5
entry:
1612.88,
exit:
1625.48,
min.ret:
-0.78%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-ACTIVE
returns:
8.75%
(6.5%),
p.close: 1497.5
entry:
1594.89,
exit:
1606.53,
min.ret:
-0.73%
Using: 5D trend, 0 Days Left
|
5D Opportunity:
SELL-ACTIVE
returns:
8.75%
(6.87%),
p.close: 1497.5
entry:
1600.38,
exit:
1611.48,
min.ret:
-0.69%
Using: 5D trend, 0 Days Left
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 2W window |
2W Opportunity:
SELL-ACTIVE
returns:
17.15%
(13.51%),
p.close: 1390.1
entry:
1577.89,
exit:
1589.46,
min.ret:
-0.73%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-ACTIVE
returns:
17.15%
(10.1%),
p.close: 1390.1
entry:
1530.53,
exit:
1531.36,
min.ret:
-0.05%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-ACTIVE
returns:
17.15%
(9.81%),
p.close: 1390.1
entry:
1526.45,
exit:
1540.45,
min.ret:
-0.92%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-ACTIVE
returns:
17.15%
(8.66%),
p.close: 1390.1
entry:
1510.55,
exit:
1517.22,
min.ret:
-0.44%
Using: 2W trend, 0 Days Left
|
2W Opportunity:
SELL-ACTIVE
returns:
17.15%
(10.84%),
p.close: 1390.1
entry:
1540.81,
exit:
1549.37,
min.ret:
-0.56%
Using: 2W trend, 0 Days Left
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 1M window |
1M Opportunity:
SELL-ACTIVE
returns:
14.77%
(11.44%),
p.close: 1418.9
entry:
1581.16,
exit:
1598.45,
min.ret:
-1.09%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
SELL-APPROACHING
returns:
14.77%
(14.77%),
p.close: 1418.9
entry:
1628.51,
exit:
1609.07,
min.ret:
1.19%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
SELL-ACTIVE
returns:
14.77%
(12.19%),
p.close: 1418.9
entry:
1591.88,
exit:
1560.93,
min.ret:
1.94%
Using: 1M trend, 0 Days Left
|
1M Opportunity:
SELL-APPROACHING
returns:
14.77%
(18.16%),
p.close: 1418.9
entry:
1676.58,
exit:
1682.18,
min.ret:
-0.33%
Using: 1M trend, 0 Days Left
|
GLENMARK's symbol current price is 1628.5 (1.83%) as on . Yesterday's close was 1599.2. It's return velocities are computed basis data from date .